Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Tenaya Therapeutics, Inc. | 120 000 | déclaré | 28 mai 2026 | tx 5+316 166 |
| DiaMedica Therapeutics Inc. | 73 288 | déclaré | 03 janv. 2023 | tx 5+105 296 |
| Terns Pharmaceuticals, Inc. | 0 | déclaré | 05 mai 2026 | tx 36+3 233 740−3 249 187 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 28 mai 2026 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 120 000 | 0.00 USD | deriv |
| 05 mai 2026 | TENDER | Terns Pharmaceuticals, Inc. | 146 614 | 53.00 USD | |
| 05 mai 2026 | TENDER | Terns Pharmaceuticals, Inc. | 8 319 | 53.00 USD | |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 150 000 | 53.00 USD | |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 955 534 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 1 250 000 | — | deriv |
| 05 mai 2026 | OTHER | Terns Pharmaceuticals, Inc. | 300 000 | — | deriv |
| 16 mars 2026 | SALE | Terns Pharmaceuticals, Inc. | 2 770 | 47.30 USD | |
| 16 mars 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 583 | 4.64 USD | |
| 16 mars 2026 | SALE | Terns Pharmaceuticals, Inc. | 11 813 | 46.57 USD | |
| 16 mars 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 583 | 0.00 USD | deriv |
| 17 févr. 2026 | SALE | Terns Pharmaceuticals, Inc. | 4 083 | 39.80 USD | |
| 17 févr. 2026 | SALE | Terns Pharmaceuticals, Inc. | 8 159 | 39.22 USD | |
| 17 févr. 2026 | SALE | Terns Pharmaceuticals, Inc. | 2 341 | 38.07 USD | |
| 17 févr. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 583 | 4.64 USD | |
| 17 févr. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 583 | 0.00 USD | deriv |
| 14 janv. 2026 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 150 000 | 0.00 USD | |
| 15 janv. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27 083 | 4.64 USD | |
| 15 janv. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27 083 | 4.64 USD | |
| 15 janv. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 583 | 4.64 USD | |
| 15 janv. 2026 | SALE | Terns Pharmaceuticals, Inc. | 61 228 | 37.02 USD | |
| 15 janv. 2026 | SALE | Terns Pharmaceuticals, Inc. | 7 521 | 37.53 USD | |
| 15 janv. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14 583 | 0.00 USD | deriv |
| 15 janv. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27 083 | 0.00 USD | deriv |
| 15 janv. 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27 083 | 0.00 USD | deriv |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 30 nov. 2024.